Sigyn Therapeutics, Inc. (SIGY)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $143.3K | $28.3K | $38.4K | — | — |
| Cost of Revenue | — | — | — | — | — | $35.7K | $9.7K | $21.4K | — | — |
| Gross Profit | — | — | — | — | — | $107.7K | $18.6K | $17.0K | — | $19.3K |
| Operating Income | -$2.52M | -$2.46M | -$2.15M | -$2.01M | -$916.4K | -$518.0K | -$1.00M | -$2.03M | — | -$2.25M |
| Net Income | -$3.34M | -$4.15M | -$2.93M | -$3.00M | -$1.26M | -$3.07M | -$2.62M | -$4.25M | — | -$2.69M |
| EPS (Diluted) | $-2.51 | $-3.77 | $-3.13 | $-0.08 | — | — | — | — | — | — |
| Total Assets | $213.7K | $321.8K | $332.9K | $710.3K | $694.1K | $0 | $862.0K | $2.07M | — | $1.43M |
| Total Liabilities | $4.67M | $3.73M | $2.24M | $974.8K | $594.9K | $910 | $4.58M | $4.16M | — | $1.51M |
| Shareholders' Equity | -$4.46M | -$3.41M | -$1.90M | -$264.6K | $99.2K | -$910 | -$3.72M | -$2.09M | -$691.8K | -$82.0K |
| Cash & Equivalents | $12.1K | $11.7K | $8.4K | $341.0K | $84.4K | $500 | $7.5K | $9.6K | $149.6K | $638.8K |
| Operating Cash Flow | -$872.4K | -$1.38M | -$1.83M | -$1.77M | -$829.8K | -$143.7K | -$286.1K | -$400.0K | — | — |
| Capital Expenditures | — | — | $860 | $29.3K | — | — | $3.0K | $940 | — | $2.5K |
| Shares Outstanding | 1.61M | 1.29M | 956.6K | 37.30M | 35.20M | 500.0K | 81.27M | 53.28M | — | 34.32M |